Femto-Pocket CXL - exciting new treatment
Posted: Mon 05 Dec 2011 11:08 am
I have just found the following article on Lynn White's website which talks about a modified CXL treatment offered by David Jory.
http://www.lwvc.co.uk/index.php?option= ... &Itemid=99. I look forward to following her blog and seeing how her patient Mark progresses since having the precedure.
Femto-Pocket CXL
Patient Blog Patient Clinical Follow Up
PROCEDURE
This new technique, performed by Mr David Jory, allows the epithelial layer to be kept intact but delivers the Riboflavin solution to the area it is needed. It is therefore an “epi-on” CXL procedure.ornea with a femtosecond laser as w
Riboflavin is injected directly into the pocket and then irradiated with the UV crosslinking machine for 30 minutes, while saline and Riboflavine are applied regularly in the normal way.
By effectively thickening the cornea with a bolus of riboflavin the treatment gets the energy to where it is needed ie the anterior half of the cornea.
Why do this procedure?
Although “Epi off” has a proven track record of effectivity, for some people it can result in several weeks of fluctuating vision as the cornea settles. This “epi on” system means the corneal surface is not affected and the small incisions created by the femtosecond laser heal very quickly. There is consequently less risk of post operative infection and a much quicker healing time and less pain than the “epi-off” procedure. It may also reduce risk of further scarring from already damaged corneas.
What are the long terms benefits/side effects?
As with any new technique, there is not yet the evidence base to say this method has the same effect as normal “epi-off”. However, as the only real argument against “epi-on” CXL is the question of whether the Riboflavin sufficiently passes through the corneal surface barrier, this procedure does address that issue.
I am currently following up patient "Mark" regualry after having this procedure on the left eye and will post his progress on this page. Although this is not scientific evidence of the efficacy of this procedure, it is hoped that it will provide useful information to anyone considering it. He will undergo the same procedure on the right eye in December.hni,
PATIENT MARK
My patient, who I will call "Mark"had been diagnosed with keratoconus 13 years ago when I first saw him on July 6th 2011. He started wearing soft lesnes to correct vision and eventualy moived to rigid types. He had also tried Hybrid lenses but had developed neovascularisation.
When I saw him, he was wearing large diameter RGP lenses (Intra Limbals) which were a poor fit with central bearing touch and signifcant edge lift. He was now struggling to maintain any kind of reasonable wear time.
Visual Acuity in the contact lenses was:
Right Eye: 6/19 (20/63) Left Eye: 6/15 (20/50)
Spectacle Prescription:
Right Eye: -8.00/-1.50 x 10 VA 6/19 (20/63)
Left Eye: -11.00/-4.50 x 120 VA: 6/36 (20/125)
Initial Topgraphy
Keratography Left Eye Topography Left Eye
He was refitted into soft lenses, understanding that time was need for the corneas to return to normal shape. During this time the average visual acuity in both eyes was around 6/15. After a couple of months, he made the decision to have CXL in order to stabilise his condition. Even though he was now 30 and had the condition long enough for it to theorectically stabilise, he felt he could only have "peace of mind" if he knew his corneas were crosslinked.
However, corneal thickness was 392 microns and there was some deep scarring present and thus "epi-off" CXL was thought to have some risk. He also was worried as to whether hos cornea and prescription would keep fluctuating after the procedure, making work difficult. He was therefore interested in having this new procedure and understood that there are no long term studies that provide evidence for its long term efficacy.
http://www.lwvc.co.uk/index.php?option= ... &Itemid=99. I look forward to following her blog and seeing how her patient Mark progresses since having the precedure.
Femto-Pocket CXL
Patient Blog Patient Clinical Follow Up
PROCEDURE
This new technique, performed by Mr David Jory, allows the epithelial layer to be kept intact but delivers the Riboflavin solution to the area it is needed. It is therefore an “epi-on” CXL procedure.ornea with a femtosecond laser as w
Riboflavin is injected directly into the pocket and then irradiated with the UV crosslinking machine for 30 minutes, while saline and Riboflavine are applied regularly in the normal way.
By effectively thickening the cornea with a bolus of riboflavin the treatment gets the energy to where it is needed ie the anterior half of the cornea.
Why do this procedure?
Although “Epi off” has a proven track record of effectivity, for some people it can result in several weeks of fluctuating vision as the cornea settles. This “epi on” system means the corneal surface is not affected and the small incisions created by the femtosecond laser heal very quickly. There is consequently less risk of post operative infection and a much quicker healing time and less pain than the “epi-off” procedure. It may also reduce risk of further scarring from already damaged corneas.
What are the long terms benefits/side effects?
As with any new technique, there is not yet the evidence base to say this method has the same effect as normal “epi-off”. However, as the only real argument against “epi-on” CXL is the question of whether the Riboflavin sufficiently passes through the corneal surface barrier, this procedure does address that issue.
I am currently following up patient "Mark" regualry after having this procedure on the left eye and will post his progress on this page. Although this is not scientific evidence of the efficacy of this procedure, it is hoped that it will provide useful information to anyone considering it. He will undergo the same procedure on the right eye in December.hni,
PATIENT MARK
My patient, who I will call "Mark"had been diagnosed with keratoconus 13 years ago when I first saw him on July 6th 2011. He started wearing soft lesnes to correct vision and eventualy moived to rigid types. He had also tried Hybrid lenses but had developed neovascularisation.
When I saw him, he was wearing large diameter RGP lenses (Intra Limbals) which were a poor fit with central bearing touch and signifcant edge lift. He was now struggling to maintain any kind of reasonable wear time.
Visual Acuity in the contact lenses was:
Right Eye: 6/19 (20/63) Left Eye: 6/15 (20/50)
Spectacle Prescription:
Right Eye: -8.00/-1.50 x 10 VA 6/19 (20/63)
Left Eye: -11.00/-4.50 x 120 VA: 6/36 (20/125)
Initial Topgraphy
Keratography Left Eye Topography Left Eye
He was refitted into soft lenses, understanding that time was need for the corneas to return to normal shape. During this time the average visual acuity in both eyes was around 6/15. After a couple of months, he made the decision to have CXL in order to stabilise his condition. Even though he was now 30 and had the condition long enough for it to theorectically stabilise, he felt he could only have "peace of mind" if he knew his corneas were crosslinked.
However, corneal thickness was 392 microns and there was some deep scarring present and thus "epi-off" CXL was thought to have some risk. He also was worried as to whether hos cornea and prescription would keep fluctuating after the procedure, making work difficult. He was therefore interested in having this new procedure and understood that there are no long term studies that provide evidence for its long term efficacy.